| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |